• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Pardes Biosciences, Inc. - Common Stock (NQ: PRDS )

    N/A UNCHANGED
    Last Price Updated: 4:00 PM EDT, Aug 30, 2023 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Pardes Biosciences, Inc. - Common Stock

    < Previous 1 2 Next >
    MediPacific Offering $2.13 Per Share Plus One Contingent Value Right Per Share in Tender Offer for Pardes Biosciences
    From Foresite Capital
    Via Business Wire
    MediPacific Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Pardes Biosciences Shares
    From MediPacific, Inc.
    Via Business Wire
    PARDES BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Pardes Biosciences, Inc. - PRDS
    From Kahn Swick & Foti, LLC
    Via Business Wire
    Why Pardes Biosciences Shares Are Rising Monday
    Pardes Biosciences Inc (NASDAQ: PRDS) shares are trading higher Monday after MediPacific agreed to acquire the company.  
    Via Benzinga
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Sculptor Capital Management Inc. (NYSE – SCU), Neoleukin Therapeutics, Inc. (Nasdaq - NLTX), Pardes Bioscience, Inc. (Nasdaq – PRDS), Great Ajax Corp. (NYSE – AJX)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    PARDES BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Pardes Biosciences, Inc. - PRDS
    From Kahn Swick & Foti, LLC
    Via Business Wire
    Recap: Pardes Biosciences Q1 Earnings
    Via Benzinga
    Pardes Biosciences Looks For Alternatives After Failed COVID-19 Study
    Via Benzinga
    INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Pardes Biosciences, Inc. and Encourages Investors with Losses to Contact the Firm
    From The Schall Law Firm
    Via Business Wire
    Benzinga's Top Ratings Upgrades, Downgrades For July 18, 2023
    Via Benzinga
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Neoleukin Therapeutics, Inc. (Nasdaq - NLTX), Pardes Bioscience, Inc. (Nasdaq – PRDS), Kaleyra, Inc. (NYSE – KLR), Great Ajax Corp. (NYSE – AJX)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    PRDS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Pardes Biosciences, Inc. Is Fair to Shareholders
    From Halper Sadeh LLC
    Via Business Wire
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
    We're starting off the week with the biggest pre-market stock movers that traders will want to keep an eye on for Monday morning! 
    Via InvestorPlace
    Why Acumen Pharmaceuticals Shares Are Trading Higher By Over 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Gainers ProMIS Neurosciences, Inc. (NASDAQ: PMN) shares jumped 126.6% to $6.37. ProMIS showcased preclinical data at the Alzheimer's Association International Conference 2023 on computationally-derived... 
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    Pardes Biosciences, Inc. (NASDAQ:PRDS) Investor Alert: Investigation over Potential Wrongdoing
    San Diego, CA -- (SBWIRE) -- 02/14/2023 -- An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Pardes Biosciences, Inc. 
    Via SBWire
    Benzinga's Top Ratings Upgrades, Downgrades For April 4, 2023
    Via Benzinga
    Investigation Announced for Investors Who Lost Money with Shares of Pardes Biosciences, Inc. (NASDAQ: PRDS)
    San Diego, CA -- (SBWIRE) -- 01/23/2023 -- An investigation was announced for investors of Pardes Biosciences, Inc. (NASDAQ: PRDS) shares over potential securities laws violations by Pardes... 
    Via SBWire
    Why Quotient Shares Are Trading Lower By More Than 48%; Here Are 37 Stocks Moving Premarket
    Gainers Netcapital Inc. (NASDAQ: NCPL) shares rose 91.3% to $2.65 in pre-market trading following Q2 results. Netcapital posted Q2 earnings of $0.04 per share on sales of $1.78 million. 
    Via Benzinga
    Why American Public Education Shares Are Trading Lower By Around 49%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Gainers ThermoGenesis Holdings, Inc. (NASDAQ: THMO) shares jumped 80% to $3.7820 after the company announced the roll out of ReadyStart cGMP Suites for early-stage cell and gene-therapy companies. 
    Via Benzinga
    Vapotherm, Redwire And These 2 Penny Stocks Insiders Are Aggressively Buying
    The Dow Jones closed lower by nearly 500 points on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern... 
    Via Benzinga
    Why AppTech Payments Are Trading Lower By Over 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Gainers 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Tuesday
      On Tuesday, 85 stocks hit new 52-week lows. 
    Via Benzinga
    Why OpGen Shares Are Trading Higher By 220%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session
    Gainers OpGen, Inc. (NASDAQ: OPGN) shares surged 220% to $0.3994 after the company announced topline data from its Unyvero urinary tract infections (UTI) clinical trial. 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Monday
      During Monday's session, 38 stocks hit new 52-week lows. 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For December 13, 2022
    Via Benzinga
    Stocks That Hit 52-Week Lows On Monday
      On Monday, 79 companies reached new 52-week lows. 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Thursday
      On Thursday, 111 stocks hit new 52-week lows. 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Wednesday
      Wednesday saw 127 companies set new 52-week lows. 
    Via Benzinga
    Why Everbridge Jumped Over 17%; Here Are 90 Biggest Movers From Friday
    Gainers Micro Focus International plc (NYSE: MFGP) shares surged 92% to close at $6.01 on Friday after the company reached an agreement with OpenText to be acquired for $6 billion. 
    Via Benzinga
    < Previous 1 2 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.